Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease
[...]genetic, biochemical, and histological testing (whenever possible) are incorporated into the diagnostic work-up and clinical management of patients with AFD. Biochemical assays, however, have their own limits (11); factors such as pH, temperature, endogenous substances including free hemoglobin...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2016-09, Vol.68 (10), p.1051-1053 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1053 |
---|---|
container_issue | 10 |
container_start_page | 1051 |
container_title | Journal of the American College of Cardiology |
container_volume | 68 |
creator | Marian, Ali J. |
description | [...]genetic, biochemical, and histological testing (whenever possible) are incorporated into the diagnostic work-up and clinical management of patients with AFD. Biochemical assays, however, have their own limits (11); factors such as pH, temperature, endogenous substances including free hemoglobin, and additional galactosidases (5) can affect the in vitro assay readouts of α-Gal activity. [...]pertinent laboratories must establish and report assay performance metrics and consider various factors that might influence the readouts, including biological sample quality. |
doi_str_mv | 10.1016/j.jacc.2016.06.026 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1819142725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109716336786</els_id><sourcerecordid>1819142725</sourcerecordid><originalsourceid>FETCH-LOGICAL-e325t-a84e1959813325ae4ebe2733becf60f040b87ccc9fca314df07617091dd57f113</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhS0EokvhD3BAlrj0kmUmju0EcVltaUGqxAE4cLIce9I6ytpLnK20_x4vbS-ckEYaP83nsfweY28R1gioPozr0Tq3rst5DaVq9YytUMq2ErLTz9kKtJAVQqfP2KucRwBQLXYv2VmtZSslwoql7Z2dJoq3lHmIfLkjfhnsbUw5ZJ4Gvome5pxidWX7-VhmmWymj3zDL8nRfgn3NB3597DbT8Rt9PwXLXybigzOLuT5NUVagnu6-Zq9GOyU6c1jP2c_rz7_2H6pbr5df91ubioStVwq2zaEnexaFEVbaqinWgvRkxsUDNBA32rnXDc4K7DxA2iFGjr0XuoBUZyzi4e9-zn9PlBezC5kR9NkI6VDNliMwKbWtfwfVCkhWoCCvv8HHdNhjuUjfymhVCNPb797pA79jrzZz2Fn56N5cr0Anx4AKg7cB5pNdoGiIx9mcovxKRgEcwrZjOYUsjmFbKBUrcQfS2OXsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1816366451</pqid></control><display><type>article</type><title>Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Marian, Ali J.</creator><creatorcontrib>Marian, Ali J.</creatorcontrib><description>[...]genetic, biochemical, and histological testing (whenever possible) are incorporated into the diagnostic work-up and clinical management of patients with AFD. Biochemical assays, however, have their own limits (11); factors such as pH, temperature, endogenous substances including free hemoglobin, and additional galactosidases (5) can affect the in vitro assay readouts of α-Gal activity. [...]pertinent laboratories must establish and report assay performance metrics and consider various factors that might influence the readouts, including biological sample quality.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2016.06.026</identifier><identifier>PMID: 27585510</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>alpha-Galactosidase ; alpha-galactosidase A ; Biomarkers ; Cardiology ; Cardiomyopathy ; Cardiomyopathy, Hypertrophic ; causality ; Chromosomes ; Deoxyribonucleic acid ; DNA ; Enzymes ; Fabry Disease - genetics ; Genetic disorders ; Genetic Testing ; Humans ; hypertrophic cardiomyopathy ; loss of function ; Mutation</subject><ispartof>Journal of the American College of Cardiology, 2016-09, Vol.68 (10), p.1051-1053</ispartof><rights>2016 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Sep 6, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109716336786$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27585510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marian, Ali J.</creatorcontrib><title>Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>[...]genetic, biochemical, and histological testing (whenever possible) are incorporated into the diagnostic work-up and clinical management of patients with AFD. Biochemical assays, however, have their own limits (11); factors such as pH, temperature, endogenous substances including free hemoglobin, and additional galactosidases (5) can affect the in vitro assay readouts of α-Gal activity. [...]pertinent laboratories must establish and report assay performance metrics and consider various factors that might influence the readouts, including biological sample quality.</description><subject>alpha-Galactosidase</subject><subject>alpha-galactosidase A</subject><subject>Biomarkers</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Hypertrophic</subject><subject>causality</subject><subject>Chromosomes</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Enzymes</subject><subject>Fabry Disease - genetics</subject><subject>Genetic disorders</subject><subject>Genetic Testing</subject><subject>Humans</subject><subject>hypertrophic cardiomyopathy</subject><subject>loss of function</subject><subject>Mutation</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFv1DAQhS0EokvhD3BAlrj0kmUmju0EcVltaUGqxAE4cLIce9I6ytpLnK20_x4vbS-ckEYaP83nsfweY28R1gioPozr0Tq3rst5DaVq9YytUMq2ErLTz9kKtJAVQqfP2KucRwBQLXYv2VmtZSslwoql7Z2dJoq3lHmIfLkjfhnsbUw5ZJ4Gvome5pxidWX7-VhmmWymj3zDL8nRfgn3NB3597DbT8Rt9PwXLXybigzOLuT5NUVagnu6-Zq9GOyU6c1jP2c_rz7_2H6pbr5df91ubioStVwq2zaEnexaFEVbaqinWgvRkxsUDNBA32rnXDc4K7DxA2iFGjr0XuoBUZyzi4e9-zn9PlBezC5kR9NkI6VDNliMwKbWtfwfVCkhWoCCvv8HHdNhjuUjfymhVCNPb797pA79jrzZz2Fn56N5cr0Anx4AKg7cB5pNdoGiIx9mcovxKRgEcwrZjOYUsjmFbKBUrcQfS2OXsQ</recordid><startdate>20160906</startdate><enddate>20160906</enddate><creator>Marian, Ali J.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20160906</creationdate><title>Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease</title><author>Marian, Ali J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e325t-a84e1959813325ae4ebe2733becf60f040b87ccc9fca314df07617091dd57f113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>alpha-Galactosidase</topic><topic>alpha-galactosidase A</topic><topic>Biomarkers</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Hypertrophic</topic><topic>causality</topic><topic>Chromosomes</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Enzymes</topic><topic>Fabry Disease - genetics</topic><topic>Genetic disorders</topic><topic>Genetic Testing</topic><topic>Humans</topic><topic>hypertrophic cardiomyopathy</topic><topic>loss of function</topic><topic>Mutation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marian, Ali J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marian, Ali J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2016-09-06</date><risdate>2016</risdate><volume>68</volume><issue>10</issue><spage>1051</spage><epage>1053</epage><pages>1051-1053</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>[...]genetic, biochemical, and histological testing (whenever possible) are incorporated into the diagnostic work-up and clinical management of patients with AFD. Biochemical assays, however, have their own limits (11); factors such as pH, temperature, endogenous substances including free hemoglobin, and additional galactosidases (5) can affect the in vitro assay readouts of α-Gal activity. [...]pertinent laboratories must establish and report assay performance metrics and consider various factors that might influence the readouts, including biological sample quality.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27585510</pmid><doi>10.1016/j.jacc.2016.06.026</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-1097 |
ispartof | Journal of the American College of Cardiology, 2016-09, Vol.68 (10), p.1051-1053 |
issn | 0735-1097 1558-3597 |
language | eng |
recordid | cdi_proquest_miscellaneous_1819142725 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | alpha-Galactosidase alpha-galactosidase A Biomarkers Cardiology Cardiomyopathy Cardiomyopathy, Hypertrophic causality Chromosomes Deoxyribonucleic acid DNA Enzymes Fabry Disease - genetics Genetic disorders Genetic Testing Humans hypertrophic cardiomyopathy loss of function Mutation |
title | Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A50%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Challenges%20in%20the%20Diagnosis%20of%20Anderson-Fabry%20Disease:%20A%20Deceptively%20Simple%20and%20Yet%20Complicated%20Genetic%20Disease&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Marian,%20Ali%20J.&rft.date=2016-09-06&rft.volume=68&rft.issue=10&rft.spage=1051&rft.epage=1053&rft.pages=1051-1053&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2016.06.026&rft_dat=%3Cproquest_pubme%3E1819142725%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1816366451&rft_id=info:pmid/27585510&rft_els_id=S0735109716336786&rfr_iscdi=true |